Cargando…
Harnessing Type I IFN Immunity Against SARS-CoV-2 with Early Administration of IFN-β
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186356/ https://www.ncbi.nlm.nih.gov/pubmed/34101091 http://dx.doi.org/10.1007/s10875-021-01068-6 |
_version_ | 1783704939145461760 |
---|---|
author | Vinh, Donald C. Abel, Laurent Bastard, Paul Cheng, Matthew P. Condino-Neto, Antonio Gregersen, Peter K. Haerynck, Filomeen Cicalese, Maria-Pia Hagin, David Soler-Palacín, Pere Planas, Anna M. Pujol, Aurora Notarangelo, Luigi D. Zhang, Qian Su, Helen C. Casanova, Jean-Laurent Meyts, Isabelle |
author_facet | Vinh, Donald C. Abel, Laurent Bastard, Paul Cheng, Matthew P. Condino-Neto, Antonio Gregersen, Peter K. Haerynck, Filomeen Cicalese, Maria-Pia Hagin, David Soler-Palacín, Pere Planas, Anna M. Pujol, Aurora Notarangelo, Luigi D. Zhang, Qian Su, Helen C. Casanova, Jean-Laurent Meyts, Isabelle |
author_sort | Vinh, Donald C. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8186356 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-81863562021-06-09 Harnessing Type I IFN Immunity Against SARS-CoV-2 with Early Administration of IFN-β Vinh, Donald C. Abel, Laurent Bastard, Paul Cheng, Matthew P. Condino-Neto, Antonio Gregersen, Peter K. Haerynck, Filomeen Cicalese, Maria-Pia Hagin, David Soler-Palacín, Pere Planas, Anna M. Pujol, Aurora Notarangelo, Luigi D. Zhang, Qian Su, Helen C. Casanova, Jean-Laurent Meyts, Isabelle J Clin Immunol Commentary Springer US 2021-06-08 2021 /pmc/articles/PMC8186356/ /pubmed/34101091 http://dx.doi.org/10.1007/s10875-021-01068-6 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Commentary Vinh, Donald C. Abel, Laurent Bastard, Paul Cheng, Matthew P. Condino-Neto, Antonio Gregersen, Peter K. Haerynck, Filomeen Cicalese, Maria-Pia Hagin, David Soler-Palacín, Pere Planas, Anna M. Pujol, Aurora Notarangelo, Luigi D. Zhang, Qian Su, Helen C. Casanova, Jean-Laurent Meyts, Isabelle Harnessing Type I IFN Immunity Against SARS-CoV-2 with Early Administration of IFN-β |
title | Harnessing Type I IFN Immunity Against SARS-CoV-2 with Early Administration of IFN-β |
title_full | Harnessing Type I IFN Immunity Against SARS-CoV-2 with Early Administration of IFN-β |
title_fullStr | Harnessing Type I IFN Immunity Against SARS-CoV-2 with Early Administration of IFN-β |
title_full_unstemmed | Harnessing Type I IFN Immunity Against SARS-CoV-2 with Early Administration of IFN-β |
title_short | Harnessing Type I IFN Immunity Against SARS-CoV-2 with Early Administration of IFN-β |
title_sort | harnessing type i ifn immunity against sars-cov-2 with early administration of ifn-β |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186356/ https://www.ncbi.nlm.nih.gov/pubmed/34101091 http://dx.doi.org/10.1007/s10875-021-01068-6 |
work_keys_str_mv | AT vinhdonaldc harnessingtypeiifnimmunityagainstsarscov2withearlyadministrationofifnb AT abellaurent harnessingtypeiifnimmunityagainstsarscov2withearlyadministrationofifnb AT bastardpaul harnessingtypeiifnimmunityagainstsarscov2withearlyadministrationofifnb AT chengmatthewp harnessingtypeiifnimmunityagainstsarscov2withearlyadministrationofifnb AT condinonetoantonio harnessingtypeiifnimmunityagainstsarscov2withearlyadministrationofifnb AT gregersenpeterk harnessingtypeiifnimmunityagainstsarscov2withearlyadministrationofifnb AT haerynckfilomeen harnessingtypeiifnimmunityagainstsarscov2withearlyadministrationofifnb AT cicalesemariapia harnessingtypeiifnimmunityagainstsarscov2withearlyadministrationofifnb AT hagindavid harnessingtypeiifnimmunityagainstsarscov2withearlyadministrationofifnb AT solerpalacinpere harnessingtypeiifnimmunityagainstsarscov2withearlyadministrationofifnb AT planasannam harnessingtypeiifnimmunityagainstsarscov2withearlyadministrationofifnb AT pujolaurora harnessingtypeiifnimmunityagainstsarscov2withearlyadministrationofifnb AT notarangeloluigid harnessingtypeiifnimmunityagainstsarscov2withearlyadministrationofifnb AT zhangqian harnessingtypeiifnimmunityagainstsarscov2withearlyadministrationofifnb AT suhelenc harnessingtypeiifnimmunityagainstsarscov2withearlyadministrationofifnb AT casanovajeanlaurent harnessingtypeiifnimmunityagainstsarscov2withearlyadministrationofifnb AT meytsisabelle harnessingtypeiifnimmunityagainstsarscov2withearlyadministrationofifnb AT harnessingtypeiifnimmunityagainstsarscov2withearlyadministrationofifnb |